With decades of experience in drug formulation and production management (including numerous patent approvals), our highly-skilled Research and Development (R&D) team is dedicated to developing solutions that enhance the delivery system of defined molecules currently available in the global market. Our particular expertise is in soft-gelatin capsule technology and control release oral solid dosage. We are capable of developing soft-gelatin capsule solutions for current as well as future products and have a demonstrated track-record of solving formulation issues in this area. Our scientists hold several patents in this field.
PuraCap scientists are particularly interested in solving formulation challenges by new options such as tablets inside capsules, various release mechanisms in soft-gel solutions and extended release formulations. PuraCap R&D’s soft gel capsule technology is just one of several innovative modes of medication delivery we utilize to make it easier for patients to consistently comply with prescribed treatment.
A wide range of PuraCap products are manufactured by our affiliated manufacturing partner, Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd, a US FDA cGMP compliant facility that complies with international regulatory standards. Our goal is to put quality first, by building quality through design and a commitment to the highest standards. We strive to exceed USFDA, cGMP standards to assure our customers the quality product they expect.
The experienced manufacturing team, led by a well-recognized technical manufacturing authority in the soft gelatin pharmaceutical capsule industry, is committed to growing our business responsibly – utilizing proven and innovative processes and procedures to produce quality products without compromise. The manufacturing team is backed by a U.S. executive team with decades of experience in FDA (Federal Drug Administration) regulated prescription drug cGMP quality system management and process validation.
The manufacturing team strives to provide cost-efficiency through manufacture at state-of-the art facilities built to USFDA specifications. Our model for success is to make use of labor as well as manufacturing efficiencies while meeting the highest quality standards. This model sets us apart from the competition. Our customers can be confident in our products—-highest quality at a competitive price. Our assurance is high quality, reliable products using the latest state of the art equipment including:
Located in the Wuhan National Bioindustry Base (Biolake) at East Lake National Innovation Demonstration Zone.
PuraCap Pharmaceutical continuously seeks opportunities to grow and strengthen our business through acquisition, licensing, strategic alliances and other professional collaborations.
As our expertise spans many therapeutic areas within the prescription drug and Over the Counter healthcare segments, we are not limited to specific disease areas or target audiences, and remain interested in exploring a wide range of business opportunities that align with our vision of building a global pharmaceutical company renowned for cost-efficient, world-class pharmaceutical products grounded in scientific integrity.
For more information on PuraCap Business Development opportunities, please contact the Business Development team at 908.941.5456